Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Boscolo A."'
Autor:
Matteo Repetto, Edoardo Crimini, Luca Boscolo Bielo, Elena Guerini-Rocco, Liliana Ascione, Andrea Bonfanti, Cristina Zanzottera, Luca Mazzarella, Alberto Ranghiero, Carmen Belli, Carmen Criscitiello, Angela Esposito, Massimo C.P. Barberis, Giuseppe Curigliano
Publikováno v:
European Journal of Cancer. 183:79-89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisabetta Zulato, Paola Del Bianco, Giorgia Nardo, Ilaria Attili, Alberto Pavan, Andrea Boscolo Bragadin, Ludovica Marra, Giulia Pasello, Matteo Fassan, Fiorella Calabrese, Valentina Guarneri, Pier Franco Conte, Stefano Indraccolo, Laura Bonanno
Publikováno v:
British Journal of Cancer. 127:2034-2042
Background Immune checkpoint inhibitors (ICIs) have revolutionised treatment of advanced non-small cell lung cancer (aNSCLC), but a proportion of patients had no clinical benefit and even experienced detrimental effects. This study aims to characteri
Autor:
Dario, Trapani, Emanuela, Ferraro, Federica, Giugliano, Luca, Boscolo Bielo, Giuseppe, Curigliano, Harold J, Burstein
Publikováno v:
Current Opinion in Oncology. 34:623-634
Triple-negative breast cancer (TNBC) has been conventionally associated with poor prognosis, as a result of limited therapeutic options. In the early setting, prognosis is informed by clinical-pathological factors; for patients receiving neoadjuvant
Autor:
Deganello, Alberto, Ruaro, Alessandra, Gualtieri, Tommaso, Berretti, Giulia, Rampinelli, Vittorio, Borsetto, Daniele, Russo, Sabino, Boscolo-Rizzo, Paolo, Ferrari, Marco, Bussu, Francesco
Peer reviewed: True
Metastatic lymph node involvement represents the most relevant prognostic factor in head and neck squamous cell carcinomas (HNSCCs), invariably affecting overall survival, disease-specific survival, and relapse-free survival.
Metastatic lymph node involvement represents the most relevant prognostic factor in head and neck squamous cell carcinomas (HNSCCs), invariably affecting overall survival, disease-specific survival, and relapse-free survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83d5004df2d4d208767b909f570178f
Autor:
Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano
Publikováno v:
Investigational New Drugs. 40:1133-1136
Purpose: TPX-0046 is designed to overcome resistance to FDA approved RET inhibitors Selpercatinib and Pralsetinib. Early prediction of resistance mechanisms to investigational drugs may facilitate subsequent drug and trial designs. This study aims to
Autor:
Alberto Vito Marcuzzo, Giancarlo Tirelli, Vincenzo Capriotti, Nicolò de Manzini, Erica Sacchet, Francesca Boscolo Nata, Azzurra Nicole Šuran-Brunelli
Publikováno v:
Surgical Oncology. 36:65-75
The main aims of the oncologic surgeon should be an early tumor diagnosis, complete surgical resection, and a careful post-treatment follow-up to ensure a prompt diagnosis of recurrence. Radiologic and endoscopic methods have been traditionally used
Autor:
Paolo Boscolo-Rizzo, Andrea D’Alessandro, Jerry Polesel, Daniele Borsetto, Margherita Tofanelli, Alberto Deganello, Michele Tomasoni, Piero Nicolai, Paolo Bossi, Giacomo Spinato, Anna Menegaldo, Andrea Ciorba, Stefano Pelucchi, Chiara Bianchini, Diego Cazzador, Giulia Ramaciotti, Valentina Lupato, Vittorio Giacomarra, Gabriele Molteni, Daniele Marchioni, Cristoforo Fabbris, Antonio Occhini, Giulia Bertino, Jonathan Fussey, Giancarlo Tirelli
Funder: Ministero della Salute; doi: http://dx.doi.org/10.13039/501100003196
BACKGROUND: Inflammatory blood markers have been associated with oncological outcomes in several cancers, but evidence for head and neck squamous cell carcinoma (HNSCC)
BACKGROUND: Inflammatory blood markers have been associated with oncological outcomes in several cancers, but evidence for head and neck squamous cell carcinoma (HNSCC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6f345d6f5b562d04a080fc5e10ffc0
Publikováno v:
Cancer journal (Sudbury, Mass.). 28(6)
The therapeutic landscape of patients with breast cancer has changed significantly with the introduction of antibody-drug conjugates (ADCs). Although human epidermal growth factor receptor 2 (HER2) has been the centerpiece of ADC development, potenti
Autor:
Paolo Boscolo-Rizzo, Anna Menegaldo, Lea Schroeder, Stefania Rigo, Margherita Tofanelli, Angelo Paolo Dei Tos, Elisa Dal Cin, Dana Holzinger, Monica Mantovani, Monia Niero, Michael Pawlita, Daniele Borsetto, Angela Guerriero, Giancarlo Tirelli, Jerry Polesel, Maria Cristina Da Mosto, Tim Waterboer, Annarosa Del Mistro, Marco Stellin
Publikováno v:
The Laryngoscope. 131:1042-1048
Objectives/hypothesis The accurate diagnostic assessment of clinically relevant human papillomavirus (HPV) infections in patients with head and neck squamous cell carcinoma represents an urgent unmet medical need. The aim of this study was to determi